Skip to main content

Table 2 Baseline and Changes from Baseline in Total Cholesterol, LDL-C, HDL-C, Triglycerides, TC:HDL Ratio, Apo A and Apo B after 6 Weeks of Treatment with either the Combination of Ezetimibe plus Fenofibrate or Atorvastatin Monotherapy

From: Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia

  Ezetimibe plus Fenofibrate Atorvastatin Monotherapy   
  Baseline 6 Weeks % Change p Value Baseline 6 Weeks % Change p Value % Difference p Value
Total Chol (mmol/L) 5.9 4.4 -25.1 < 0.001 5.8 4.4 -24.6 < 0.001 -0.4 0.806
LDL-C (mmol/L) 3.8 2.4 -34.6 < 0.001 3.7 2.3 -36.7 < 0.001 2.1 0.46
HDL-C (mmol/L) 1.4 1.5 10.0 0.002 1.3 1.5 8.9 0.006 1.1 0.778
Triglycerides (mmol/L) 1.5 1.0 -25.4 < 0.001 1.6 1.4 -14.5 0.002 -11.0 0.079
TC:HDL Ratio 4.3 3.0 -29.0 < 0.001 4.4 3.1 -28.7 < 0.001 -0.2 0.904
Apo A 1.27 1.32 4.5 0.041 1.29 1.30 1.5 0.493 3.04 0.295
Apo B 1.21 0.82 -31.8 < 0.001 1.19 0.82 -29.8 < 0.001 -1.99 0.392